The finding suggests that future antiobitic candidates could be found within the human body.
A new study has found that better compliance with treatment protocols can lead to quicker clearance of soft skin and tissue infections caused by methicillin-resistant Staphylococcus aureus (MRSA).
A new study led by researchers at the Johns Hopkins Bloomberg School of Public Health indicates that a clinical decision tree can be used to determine whether a patient with bacteremia has been infected by extended spectrum beta-lactamase (ESBL)-producing bacteria, which are more difficult to treat due to antibiotic resistance.
Ebola virus (EBOV) from the West Africa outbreak survived more than 30 days in blood in syringe needles—even in hot, humid conditions— and 6 days on paper money under experimental conditions, according to a study yesterday in the Journal of Infectious Diseases.
Study finds household contamination may increase the risk of recurrence.
A nonprofit group's annual report on US public health spending says overall funding is still stuck below where it was before the recession of 2008-09, although spending by states may be picking up a bit.
"Federal funding for public health has remained relatively level for years," says the report by the Trust for America's Health (TFAH), based in Washington, DC.
MRSA infections have declined in recent years, paralleling a drop in adults.
Saudi Arabia's Ministry of Health (MOH) reported a new MERS-CoV case today in the capital city of Riyadh.
The case involves a 21-year-old Saudi woman who is in critical condition with a MERS-CoV (Middle East respiratory syndrome coronavirus) infection. She is not a healthcare worker and was not exposed to other MERS patients, the agency said. No other risk factors were noted.
Mapp Biopharmaceuticals announced yesterday that its experimental Ebola treatment ZMapp received fast-track status to gain US Food and Drug Administration (FDA) approval.